A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- Nanobiosensors in Healthcare Market is projected to register a healthy CAGR of 9.84% By 2024on September 6, 2019 at 1:05 pm
Nanobiosensors are analytical devices which are used for molecular detection ... the nanobiosensors in healthcare market has been segmented into hospitals and clinics, diagnostic centers, point of ...
- Sona Nanotech: Using Nanotechnology to Transform Diagnostics and Healthcareon September 6, 2019 at 11:01 am
Gemini is a CTAB-free gold nanorod product that enables multiplexing of lateral flow diagnostic tests for multiple analytes on just one device ... in human health point-of-care testing and ...
- Microfluidic Devices Market Size Is Expected To Reach USD 14.2 Billion at a 19.7% CAGR Till 2025 | MRFRon September 5, 2019 at 7:23 am
analytical devices, point of care diagnosis, clinical and veterinary diagnostics, and pharmaceutical and life science research. Based on the region, the microfluidic devices market report covers the ...
- Point Of Care (POC) Diagnostics Market is anticipated to reach USD 34.6 billion by 2025|Roche Diagnostics, Siemens AGon September 5, 2019 at 6:39 am
Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in patient's community, usually outside of clinical labs. The point of care allows earlier diagnostics ...
- Microfluidics Markets: Worldwide Forecasting to 2022 - ResearchAndMarkets.comon September 5, 2019 at 4:30 am
in-vitro diagnostics, and drug delivery devices. The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising ...
- Global Microfluidics Market Review 2017-2019 & Forecast to 2022 Featuring Fluidigm, Roche, Agilent Technologies, Illumina, Shimadzu, Abbott, and Moreon September 5, 2019 at 4:00 am
According to analysis, the market for microfluidic devices all over the ... adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic ...
- Global Point-Of-Care-Diagnostics Market Size, Share, Growth, Trends and Forecast to 2025on September 4, 2019 at 4:13 am
The emerging need for the expansion of next-gen point-of-care diagnostic devices for the resolution of gaps in stroke clinical practices is expected to provide a substantial boost to the point-of-care ...
- OPKO Health Switches to Multichannel Veeva CRM to Drive More Effective Customer Engagementon September 4, 2019 at 4:03 am
See our infographic to learn how Veeva CRM is enabling real-time reps to do more from any device ... Claros® 1 is a point-of-care diagnostics platform with a total PSA test approved by the ...
- True Diagnostics™ and Veravas, Inc. Announce Strategic Alliance in the Commercialization of VeraTest Biotin™on September 3, 2019 at 7:36 am
True Diagnostics, Inc. (True), a leading company for Point of Care (POC) answers, and Veravas ... Our collaboration with True utilizing their device technology has resulted in a test that’s easy to ...
- Global Point of Care Diagnostics Market is Expected to Reach $57.85 Billion by 2026on August 29, 2019 at 7:08 am
Rising usage of home-based POC devices, growing number of regulatory approvals ... Request for sample here: https://www.strategymrc.com/report/point-of-care-diagnostics-market/request-sample Point of ...
via Bing News